Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cefditoren pivoxil - Meiji Seika Pharma

Next Previous
X
Search
Drug Profile

Cefditoren pivoxil - Meiji Seika Pharma

Alternative Names: CDN; CDN-PI; CDTR-PI; CRTX-062; CRTX-068; ME-1207; Meiact; Meiact MS Fine Granules 10% - Meiji Seika Pharma; Spectracef

Latest Information Update: 28 Feb 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Meiji Seika Kaisha
  • Developer Cornerstone Therapeutics; Meiji Seika Pharma; Tedec Meiji
  • Class Anti-infectives; Antibacterials; Cephems; Small molecules
  • Mechanism of Action Cell wall inhibitors; Interleukin 6 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute exacerbations of chronic bronchitis; Bacterial infections; Community-acquired pneumonia; Otitis media; Respiratory tract infections; Skin and soft tissue infections; Tonsillitis
  • Suspended Pharyngitis
  • No development reported COVID-19 pneumonia; Urinary tract infections

Most Recent Events

  • 28 Feb 2024 No recent reports of development identified for clinical-Phase-Unknown development in COVID-19 pneumonia(In adults) in Spain (PO)
  • 05 Jan 2021 Clinical trials in COVID-19 pneumonia (In adults) in Spain (PO) in January 2021 (NCT04709172)
  • 01 Aug 2019 Launched for Bacterial infections (In children) in Indonesia (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top